Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yetrib Hathout

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Cell Death and Differentiation|November 12, 2016
Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophyMaria C Vila, Sree Rayavarapu, Marshall W Hogarth, et al.
Cell Reports|December 29, 2023
Toxoplasma membrane inositol phospholipid binding protein TgREMIND is essential for secretory organelle function and host infectionRodrigue Houngue, Lamba Omar Sangaré, Tchilabalo Dilezitoko Alayi, et al.
Molecular & Cellular Proteomics : MCP|January 9, 2013
Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouseSree Rayavarapu, William Coley, Erdinc Cakir, et al.
Toxicology Reports|July 28, 2015
The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouseAiping Zhang, Kitipong Uaesoontrachoon, Conner Shaughnessy, et al.
Journal of Neuromuscular Diseases|September 27, 2021
Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping TherapyJames S Novak, Rita Spathis, Utkarsh J Dang, et al.
Frontiers in Molecular Neuroscience|January 27, 2025
Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targetsNalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
Clinical Proteomics|June 5, 2026
Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophyAhmed Naveed, Elissa Recinos, Dexter Chow, et al.
IBRO Neuroscience Reports|February 23, 2023
Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trialsNalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
Nature Communications|March 25, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Steroids|September 16, 2025
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trialsAna de Vera, Paula R Clemens, Utkarsh J Dang, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Cell Death and Differentiation|November 12, 2016
Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophyMaria C Vila, Sree Rayavarapu, Marshall W Hogarth, et al.
Cell Reports|December 29, 2023
Toxoplasma membrane inositol phospholipid binding protein TgREMIND is essential for secretory organelle function and host infectionRodrigue Houngue, Lamba Omar Sangaré, Tchilabalo Dilezitoko Alayi, et al.
Molecular & Cellular Proteomics : MCP|January 9, 2013
Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouseSree Rayavarapu, William Coley, Erdinc Cakir, et al.
Toxicology Reports|July 28, 2015
The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouseAiping Zhang, Kitipong Uaesoontrachoon, Conner Shaughnessy, et al.
Journal of Neuromuscular Diseases|September 27, 2021
Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping TherapyJames S Novak, Rita Spathis, Utkarsh J Dang, et al.
Frontiers in Molecular Neuroscience|January 27, 2025
Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targetsNalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
Clinical Proteomics|June 5, 2026
Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophyAhmed Naveed, Elissa Recinos, Dexter Chow, et al.
IBRO Neuroscience Reports|February 23, 2023
Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trialsNalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
Nature Communications|March 25, 2018
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscleJames S Novak, Marshall W Hogarth, Jessica F Boehler, et al.
Steroids|September 16, 2025
Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trialsAna de Vera, Paula R Clemens, Utkarsh J Dang, et al.
Pageof 12